BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 18035584)

  • 1. Behçet's disease: ocular effects and treatment.
    Deuter CM; Kötter I; Wallace GR; Murray PI; Stübiger N; Zierhut M
    Prog Retin Eye Res; 2008 Jan; 27(1):111-36. PubMed ID: 18035584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future treatments for Behçet's uveitis: road to remission.
    Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Dick AD; Adán A
    Int Ophthalmol; 2014 Apr; 34(2):365-81. PubMed ID: 23729309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behçet's disease.
    Bonfioli AA; Orefice F
    Semin Ophthalmol; 2005; 20(3):199-206. PubMed ID: 16282155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behçet's disease--a contemporary review.
    Mendes D; Correia M; Barbedo M; Vaio T; Mota M; Gonçalves O; Valente J
    J Autoimmun; 2009; 32(3-4):178-88. PubMed ID: 19324519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of streptococcal hypersensitivity in the pathogenesis of Behçet's Disease.
    Kaneko F; Oyama N; Yanagihori H; Isogai E; Yokota K; Oguma K
    Eur J Dermatol; 2008; 18(5):489-98. PubMed ID: 18693149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behçet's disease: epidemiology and eye manifestations in German and Mediterranian patients.
    Zierhut M; Saal J; Pleyer U; Kötter I; Dürk H; Fierlbeck G
    Ger J Ophthalmol; 1995 Jul; 4(4):246-51. PubMed ID: 7492938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.
    Mishima S; Masuda K; Izawa Y; Mochizuki M; Namba K
    Trans Am Ophthalmol Soc; 1979; 77():225-79. PubMed ID: 397657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behcet disease in adult Druzes in north Israel: the influence of ethnic origin on disease expression and severity.
    Rozenbaum M; Boulman N; Slobodin G; Zisman D; Mader R; Yankevitch A; Weinberger A; Rosner I
    J Clin Rheumatol; 2007 Jun; 13(3):124-7. PubMed ID: 17551376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular manifestations of Behçet's disease].
    Cassoux N; Fardeau C; Lehoang P
    Ann Med Interne (Paris); 1999 Nov; 150(7):529-34. PubMed ID: 10637668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The eye and Behçet's disease].
    Khairallah M; Ben Yahia S; Kahloun R; Khairallah-Ksiaa I; Messaoud R
    J Fr Ophtalmol; 2012 Dec; 35(10):826-37. PubMed ID: 23083770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eye and Behçet's disease].
    Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
    J Fr Ophtalmol; 2019 Jun; 42(6):626-641. PubMed ID: 31164292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye and Behçet's disease.
    Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
    J Fr Ophtalmol; 2019 Apr; 42(4):e133-e146. PubMed ID: 30850197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behçet's disease.
    Yesudian PD; Edirisinghe DN; O'Mahony C
    Int J STD AIDS; 2007 Apr; 18(4):221-7. PubMed ID: 17509169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease.
    Stanford M; Whittall T; Bergmeier LA; Lindblad M; Lundin S; Shinnick T; Mizushima Y; Holmgren J; Lehner T
    Clin Exp Immunol; 2004 Jul; 137(1):201-8. PubMed ID: 15196263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular manifestations in Behçet's disease].
    Zeghidi H; Saadoun D; Bodaghi B
    Rev Med Interne; 2014 Feb; 35(2):97-102. PubMed ID: 24290834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behçet's disease: external ear involvement.
    Miura MS; Lubianca Neto JF; Krumenauer RC; Prates K; de Castro R; Saffer M
    Int J Pediatr Otorhinolaryngol; 2004 Jun; 68(6):817-21. PubMed ID: 15126024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular manifestations in Behçet's disease].
    Desbois AC; Terrada C; Cacoub P; Bodaghi B; Saadoun D
    Rev Med Interne; 2018 Sep; 39(9):738-745. PubMed ID: 29625716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behçet's disease.
    Kurokawa MS; Yoshikawa H; Suzuki N
    Semin Respir Crit Care Med; 2004 Oct; 25(5):557-68. PubMed ID: 16088499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Behçet disease.
    Khairallah M; Accorinti M; Muccioli C; Kahloun R; Kempen JH
    Ocul Immunol Inflamm; 2012 Oct; 20(5):324-35. PubMed ID: 23030353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
    Park JY; Chung YR; Lee K; Song JH; Lee ES
    Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.